Vaccitech PLC reports results for the quarter ended in June - Earnings Summary

Barinthus Biotherapeutics

10/08/2023 15:16

* Vaccitech PLC  VACC.OQ  reported a quarterly adjusted loss
of 62
cents​​ per share for the quarter ended in June. The mean
expectation of three analysts for the quarter was for a loss
of 55 cents per share.
    * Revenue fell 98% to $334.00 thousand from a year ago;
analysts
expected $600.00 thousand. 
    * Vaccitech PLC's reported EPS for the quarter was a loss
of 62
cents​.
    * The mean earnings estimate of analysts had fallen by
about 4.5%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Vaccitech PLC shares had risen by 6.8% this quarter and
lost 6.4% so far this year.
    * The company reported a quarterly loss of $23.8 million.
    * Wall Street's median 12-month price target for Vaccitech
PLC is
$15.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
August 10 at 02:16 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      -0.55          -0.62          Missed
 Mar. 31 2023      -0.50          -0.48          Beat
 Dec. 31 2022      -0.42          -0.57          Missed
 Sep. 30 2022      -0.33          0.22           Beat